ResMed (RMD) Stock Analysis & AI Equity Report
ResMed (RMD) overview
ResMed (RMD) stock analysis and AI equity research. For financial year 2026, Valuatum's model shows revenue of USD 5,653m and operating profit of USD 1,887m; the year-end share price was 194.88 USD and market capitalisation was USD 28,109m. ResMed is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get ResMed's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About ResMed
ResMed develops digital health solutions and cloud-connected medical devices for sleep and breathing disorders and related conditions. Its offerings include CPAP systems, ventilation and life-support devices, diagnostic products, masks, accessories, dental devices, and cloud-based applications and software for connected care. The company also provides in-home testing services and management software. Its customers include patients, clinicians, home medical equipment providers, and residential care providers.
Generate the ResMed report
ResMed is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for ResMed and represent financial year 2026. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on ResMed
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.